Clinical trial · Observational
Prospective Registration Study of Totally Laparoscopy Versus Laparoscopy Assisted Colon Cancer Surgery
NCT04853784CI-TRIAL-00051391STARS-CC01unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a comparison of totally laparoscopic and laparoscopic-assisted colon cancer resection, a prospective registration study comparing the safety and benefits of the two operations
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Intracorporeal Anastomosis | — | UNRESOLVED | — |
| Surgery | — | UNRESOLVED | — |
| Totally Laparoscopic | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| intracorporeal anastomosis | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Totally laparoscopic colon surgery
- description
- Totally laparoscopic colon surgery/intracorporeal anastomosis
- interventionNames
- Procedure: intracorporeal anastomosis
- label
- Laparoscopic-assited colon surgery
- description
- Laparoscopic-assited colon surgery/extracorporeal anastomosis
- interventionNames
- Procedure: intracorporeal anastomosis
Primary outcomes (1)
- measure
- Incidence of postoperative complications
- timeFrame
- 30 days after operation
- description
- Complication incidence 30 days after operation
Secondary outcomes (9)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age: 18-80 years old, male or female; 2. Colon cancer (ascending colon, transverse colon, descending colon, sigmoid colon) is diagnosed by histology or cytology; 3. The clinical stage is T1-4aN0-2M0; 4 No multiple distant metastases; 5\. ECOG score 0-2; 6. Heart, lung, liver, and kidney functions can tolerate surgery; 7. Patients and their families can understand and are willing to participate in this clinical study, and sign an informed consent. Exclusion Criteria: 1. Past history of malignant colorectal tumors or recent diagnosis combined with other malignant tumors; 2. Patients with intestinal obstruction, intestinal perforation, intestinal bleeding, etc. who need emergency surgery; 3. Neighboring organs need to be combined with organ resection; 4. New adjuvant therapy before surgery; 5. ASA grade ≥ grade IV and/or ECOG physical status score\> 2 points; 6. Those who have severe liver and kidney function, cardiopulmonary function, blood coagulation dysfunction, or combined with serious underlying diseases that cannot tolerate surgery; 7. History of severe mental illness; 8. Pregnant or lactating women; 9. Patients with other clinical and laboratory conditions considered by the investigator should not participate in the trial.
References
Publications (0)
Data not yet available
No reference posted for this study.